π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
SBRT Combined with CAPEOX, Bevacizumab, and PD-1 Inhibitor in RAS-Mutant, M...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-02
Trial ID
NCT06835179
Treatments Being Tested
This study is conducted to evaluate the efficacy, prognosis, adverse effect...
Status
Recruiting
Location
The Second Affiliated Hospital of Fujian Medical University
Start Date
2020-05-19
Trial ID
NCT05713994
To explore the efficiency and safety of Tislelizumab combinated with carbop...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-04-20
Trial ID
NCT06366945
This study will look at whether adding daily oral zinc supplements to targe...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital)
Start Date
2026-09-01
Trial ID
NCT07793695
This is a multicenter, open-label, prospective, single-arm, phase II study ...
Status
Recruiting
Location
Fujian Medical University Union Hospital
Start Date
2025-10-25
Trial ID
NCT07296705
Treatments Being Tested
The purpose of this observational study is to evaluate the impact of differ...
Status
Completed
Location
Jiangsu Cancer Hospital
Start Date
2019-11-01
Trial ID
NCT07098104
Treatments Being Tested
This is a prospective, open, multicenter, Phase II single-arm clinical stud...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-03-31
Trial ID
NCT06908733
Combination treatment with antiangiogenic agents and anti-programmed cell d...
Status
Unknown
Location
Zhongshan Hospital, Fudan University
Start Date
2020-12-23
Trial ID
NCT04639284
Treatments Being Tested
The survival of the refractory CRC is dismal and therapy options are limite...
Status
Completed
Location
Hunan Cancer Hospital
Start Date
2019-01-01
Trial ID
NCT06011330
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of hepatic...
Status
Active Not Recruiting
Location
The first hospital of China medical university
Start Date
2024-08-16
Trial ID
NCT06632106